Pieris Pharmaceuticals, Inc. PIRS
Set alert
13.60 +13.60 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 17.96M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -68.00
- Beta
- 0.66
- Short ratio
- 3.52
- Inst. own
- 52.92%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 13, 2024
- 50-d avg
- 16.46
- 200-d avg
- 14.03
- 1y target
- 0.00
Analyst view
Consensus: none
Price target (mean) 0.00
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 13, 2020 | Baird | Upgrade | Neutral | Outperform |
| Jul 30, 2019 | Baird | Downgrade | Outperform | Neutral |
| May 14, 2019 | Baird | Initiated | — | Outperform |
| May 4, 2018 | Cowen & Co. | Initiated | — | Outperform |
| Mar 19, 2018 | Evercore ISI Group | Initiated | — | Outperform |
| Mar 19, 2018 | Jefferies | Initiated | — | Buy |
| Jan 17, 2018 | William Blair | Initiated | — | Outperform |
| May 30, 2017 | Rodman & Renshaw | Initiated | — | Buy |
| Mar 9, 2016 | JMP Securities | Maintained | — | Market Outperform |
| Aug 12, 2015 | JMP Securities | Initiated | — | Market Outperform |
| Jul 28, 2015 | Oppenheimer | Initiated | — | Outperform |
| Jul 27, 2015 | Oppenheimer | Initiated | — | Outperform |
| Jul 22, 2015 | Roth Capital | Initiated | — | Buy |